Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of glycolysis modulates retinal endothelial cell function and pathological neovascularization. | Exp Eye Res | 2025 | 40701532 | PubTator, text mining | PubMed |
| Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndrome. | Alzheimers Dement | 2025 | 40667702 | PubTator, text mining | PubMed |
| Metabolic changes of peripheral blood mononuclear cells are related to the high cytokine levels in patients with pulmonary arterial hypertension. | Life Sci | 2025 | 40645402 | PubTator, text mining | PubMed |
| Potential applications of PFKFB in cancer treatment strategies. | Int J Biol Macromol | 2025 | 40639515 | PubTator, text mining | PubMed |
| Targeting PFKFB3 to restore glucose metabolism in acute pancreatitis via nanovesicle delivery. | Mol Med | 2025 | 40618046 | PubTator, text mining | PubMed |
| MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease. | Neurochem Res | 2025 | 40586827 | PubTator, text mining | PubMed |
| Regulatory mechanisms of PFKFB2 in glycolysis and tumor metabolism: implications for cancer therapy. | Carcinogenesis | 2025 | 40538377 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Screening and Identification of Basement Membrane-Related Gene Signatures for Diagnosis in Keratoconus Through WGCNA and Machine Learning. | J Ophthalmol | 2025 | 40487778 | PubTator, text mining | PubMed |
| Glycolytic control proteins in urinary extracellular vesicles are elevated during kidney transplant T cell-mediated rejection. | BMC Nephrol | 2025 | 40481420 | PubTator, text mining | PubMed |
| PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11/xCT dephosphorylation. | Int Immunopharmacol | 2025 | 40435821 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer. | Cancers (Basel) | 2025 | 40427135 | PubTator, text mining | PubMed |
| Mechanistic studies of PFKFB2 reveal a novel inhibitor of its kinase activity. | PLoS One | 2025 | 40402947 | PubTator, text mining | PubMed |
| The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year report. | Alzheimers Dement | 2025 | 40371686 | PubTator, text mining | PubMed |
| Engineering Mucor circinelloides for enhanced lipid production through homologous overexpression of phosphofructokinase (PFK1 and PFK2) coupled with in-silico modeling analysis. | Int J Biol Macromol | 2025 | 40339842 | PubTator, text mining | PubMed |
| A 40-year challenge to resolve clinical questions through experimental/laboratory techniques. | Endocr J | 2025 | 40335288 | PubTator, text mining | PubMed |
| METTL3 mediates atheroprone flow-induced glycolysis in endothelial cells. | Proc Natl Acad Sci U S A | 2025 | 40327688 | PubTator, text mining | PubMed |
| Transcriptomic implications of low herbicide concentrations in hepatic cells: Insights into the individual and combined effects of 2,4-D, glyphosate, and AMPA. | Toxicol Lett | 2025 | 40294809 | PubTator, text mining | PubMed |
| Complosome as a new intracellular regulatory network in both normal and malignant hematopoiesis. | Leukemia | 2025 | 40269269 | PubTator, text mining | PubMed |
| TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc. | Cell Death Dis | 2025 | 40246827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=11